Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium.
about
Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary diseaseβ(2) -adrenoceptor agonists: current and future directionSafety and efficacy of 12-week or longer indacaterol treatment in moderate-to-severe COPD patients: a systematic review.Indacaterol on dyspnea in chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized placebo-controlled trials.V0162 a new long-acting bronchodilator for treatment of chronic obstructive lung diseases: preclinical and clinical resultsEffects of indacaterol versus tiotropium on respiratory mechanics assessed by the forced oscillation technique in patients with chronic obstructive pulmonary disease.Indacaterol (arcapta neohaler) for chronic obstructive pulmonary diseaseIndacaterol in chronic obstructive pulmonary disease: an update for clinicians.A UK-based cost-utility analysis of indacaterol, a once-daily maintenance bronchodilator for patients with COPD, using real world evidence on resource use.Dual Bronchodilator Therapy with Umeclidinium/Vilanterol Versus Tiotropium plus Indacaterol in Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial.Indacaterol: a comprehensive review.Chronic obstructive pulmonary disease in China: the potential role of indacaterolGuidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.Effects of indacaterol versus tiotropium on exercise tolerance in patients with moderate COPD: a pilot randomized crossover study.Efficacy of indacaterol on quality of life and pulmonary function in patients with COPD and inhaler device preferences.Efficacy and safety of coadministration of once-daily indacaterol and glycopyrronium versus indacaterol alone in COPD patients: the GLOW6 study.An update on the use of indacaterol in patients with COPD.Profiling the bronchodilator effects of the novel ultra-long-acting β2-agonist indacaterol against established treatments in chronic obstructive pulmonary disease.Long-acting β-adrenoceptor agonists in the management of COPD: focus on indacaterol.Optimum bronchodilator combinations in chronic obstructive pulmonary disease: what is the current evidence?Indacaterol: a review of its use as maintenance therapy in patients with chronic obstructive pulmonary disease.Indacaterol: a new long-acting β2-agonist in the management of chronic obstructive pulmonary disease.Indacaterol: a novel long-acting β(2) -agonist.Future of chronic obstructive pulmonary disease management.A review of the advances in chronic obstructive pulmonary disease treatment.Indacaterol 75 μg once daily for the treatment of patients with chronic obstructive pulmonary disease: a North American perspective.Role of indacaterol and the newer very long-acting β2-agonists in patients with stable COPD: a reviewTurning a molecule into a medicine: the development of indacaterol as a novel once-daily bronchodilator treatment for patients with COPD.Combination therapy with indacaterol and glycopyrronium bromide in the management of COPD: an update on the evidence for efficacy and safety.Bronchoprotective tolerance with indacaterol is not modified by concomitant tiotropium in persistent asthma.Lung Delivery of Indacaterol and Mometasone Furoate Following Inhalation of QMF149 in Healthy Volunteers.The role of indacaterol for chronic obstructive pulmonary disease (COPD).Clinical trial design in chronic obstructive pulmonary disease: current perspectives and considerations with regard to blinding of tiotropium.Clinical trial simulation to assist in COPD trial planning and design with a biomarker-based diagnostic: when to pull the trigger?Computed tomography assessment of airway dimensions with combined tiotropium and indacaterol therapy in COPD patients.FLIGHT1 and FLIGHT2: Efficacy and Safety of QVA149 (Indacaterol/Glycopyrrolate) versus Its Monocomponents and Placebo in Patients with Chronic Obstructive Pulmonary Disease.Collection, synthesis, and interpretation of evidence: a proof-of-concept study in COPD.
P2860
Q24200476-56867858-3DAB-4C5E-A6E6-E5C2DB21F52AQ24604047-ECAE95B7-1A47-4406-8D4C-FDDBF48B38DFQ34544020-33E764FF-BCF2-4A62-A0B8-8B36A8590342Q34686851-5813F537-4EDD-40A4-9D5B-DEEDAB23E06EQ35710238-051F9CD6-C6AC-4859-856F-45B515B303C9Q35766357-95FEE366-92D7-4E64-95DB-2D68D19C5ECAQ35958673-55F6D59A-B2C9-4629-8867-536BC6C297E4Q36443777-8D237953-4A19-4F38-BF2C-F05DE82CC356Q36875110-59535A28-4AE8-4B71-BC30-50C8197517E7Q36924015-AF75BC91-6CFB-409F-9261-A4C6D6AC743BQ37057061-F058E4B6-2BE1-4DDF-A2D0-1EF062C83C2EQ37128034-36FE523F-2FC4-45F9-8390-BDC3651E5E16Q37177278-51A1221B-36A6-4ED7-999A-3FE07824F313Q37392356-6E71ED6F-41DE-433D-B8C3-B1E4ED799BADQ37524951-61ADCBB0-82C2-437B-8486-783ECE1403B3Q37614103-FB6244F1-58DE-4902-ABDC-535A4460C7B5Q37808058-BCD36055-4A05-4191-AD04-EDE12B8D3B4DQ37896372-72110276-C73A-42DB-8300-5DC47CD9FFB7Q37911291-C9E4E116-4A7E-4AE8-A0B5-C9A2808E4327Q37982432-23F3F7EF-7871-4D01-879A-1904AAAFE16EQ37987211-DDC54274-E7B4-4384-9A20-7F098E55D154Q37999465-425A46AD-6076-449B-94B6-827176A52641Q38002357-010814B9-0BB0-4FDD-A40C-AF55B5F3151BQ38025725-7DD467FA-FF5F-4FE9-98F9-194CC01AD19FQ38053126-AA8C9DF6-42BD-4FEF-9FAB-0AA593B6AF5CQ38072277-CBD39BE1-7016-4351-99EA-DA6C7D6D5409Q38148145-219DDD7B-BAB0-43E6-A1F5-A1064DE306F9Q38248438-E5E073A7-EC4E-4A5B-B3F1-B17E642A96D3Q38359553-05709669-1CFD-4C1A-A8BB-D99E68DD602EQ38700260-84B3D12C-A692-4FE7-B160-BAAC7BAAF5C7Q39678636-AB5A418C-871D-43C2-AEEF-C5F1C8180419Q41853545-AB1A9FBD-6689-4B0A-8262-A3F4871E406DQ42533804-0E35ECB6-E079-474F-AC15-B1D3AF20156AQ43554429-86056C9C-9524-4264-8AEA-558822E98398Q48080686-A1400107-B43F-4B96-A7E7-CE240660DF48Q50954570-00737C29-4A73-4F2D-B03F-2AC02630038BQ51278385-BD3A13F2-B9F0-4CFB-97AB-F3461435D3E1
P2860
Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Indacaterol provides 24-hour b ...... ed comparison with tiotropium.
@ast
Indacaterol provides 24-hour b ...... ed comparison with tiotropium.
@en
Indacaterol provides 24-hour b ...... ed comparison with tiotropium.
@nl
type
label
Indacaterol provides 24-hour b ...... ed comparison with tiotropium.
@ast
Indacaterol provides 24-hour b ...... ed comparison with tiotropium.
@en
Indacaterol provides 24-hour b ...... ed comparison with tiotropium.
@nl
prefLabel
Indacaterol provides 24-hour b ...... ed comparison with tiotropium.
@ast
Indacaterol provides 24-hour b ...... ed comparison with tiotropium.
@en
Indacaterol provides 24-hour b ...... ed comparison with tiotropium.
@nl
P2093
P2860
P356
P1433
P1476
Indacaterol provides 24-hour b ...... ded comparison with tiotropium
@en
P2093
Benjamin Kramer
Damon Jack
INTIME study investigators (INdacaterol & TIotropium: Measuring Efficacy)
Mark Higgins
Roger Owen
Simon Piggott
P2860
P2888
P356
10.1186/1465-9921-11-135
P577
2010-10-05T00:00:00Z
P5875
P6179
1053059746